|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Net Loss | |
| Depreciation and amortization | |
| Amortization of right of use asset - operating | |
| Amortization of right-of-use asset - financing | |
| Gain on sale of intangible assets | |
| Share-based compensation | |
| Accounts receivable | |
| Accrued interest receivable | |
| Deposits | |
| Prepaid expenses | |
| Inventory | |
| Accounts payable | |
| Payroll liabilities | |
| Accrued interest – line of credit | |
| Deferred revenue | |
| Lease liability - operating | |
| Net Cash Used for Operating Activities | |
| Purchase of furniture & equipment | |
| Purchase of intangible assets | |
| Sale of intangible assets | |
| Loans to start-up clinics | |
| Net Used for Investing Activities | |
| Payments made on lease liability - finance | |
| Line of credit | |
| Proceeds from sales of common stock | |
| Net Cash Provided by Financing Activities | |
| Net Increase in Cash | |
| Cash at Beginning of Year | |
| Cash at End of Year | |
| Cash paid for interest | |
| Cash paid for taxes | |
| Supplemental disclosure of non-cash investing and financing activities: | |
| Shares to be issued for investment in non-consolidated business entity | |
| Shares issued for acquisition of Biolete, LLC | |
| Receivable on sale of inventory asset | |
| Operating right-of-use asset obtained though operating lease obligation | |
| Finance right-of-use asset obtained through finance lease obligation | |
| Cancellation of shares |
Loading...
